My lab focuses on engineering of antibodies and immune cells to treat solid tumors in children.
Nai-Kong V. Cheung, MD, PhD
Professor
Research Focus
Physician-scientist Nai-Kong Cheung focuses on engineering of antibodies and immune cells to treat solid tumors in children.Education
- MD, Harvard Medical School
- PhD, Harvard University
- Office Phone: 646-888-2313
- Lab Phone: 646-888-2320
Lab Members
Konstantin Dobrenkov
Special Fellow
Sayed Shahabuddin Hoseini
Research Fellow
Brian H. Santich
Graduate Student
Maya Suzuki
Fellow
Lin Lin Wang
Research Fellow
Zhihao Wu
Research Fellow
Mahiuddin Ahmed
Assistant Attending for Immunotherapies
Irene Cheung
Associate Member and Attending, Pediatrics
Yi Feng
Research Assistant
Hong-fen Guo
Research Assistant/Specialist
Hoa Tran
Research Assistant
Hong Xu
Senior Research Scientist
Publications
- Cheung NK, Zhang J, Lu C, Parker M, Bahrami A, Tickoo SK, Heguy A, Pappo AS, Federico S, Dalton J, Cheung IY, Ding L, Fulton B, Wang J, Chen X, Becksfort J, Wu J. Billups CA, Ellison D, Mardis ER, Wilson RK, Downing JR, Dyer MA. JAMA. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA. 2012 Mar 14;307(10):1062-71. doi: 10.1001/jama.2012.228.
- Cheung NK, Cheung IY, Kushner BH, Ostrovnaya I, Kramer K, Modak S. Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission. J Clin Oncol. 2012 Sep 10;30(26):3264-70. doi: 10.1200/JCO.2011.41.3807. Epub 2012 Aug 6.
